3207 related articles for article (PubMed ID: 26569387)
1. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
[TBL] [Abstract][Full Text] [Related]
2. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
[TBL] [Abstract][Full Text] [Related]
5. Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging.
Alhurani RE; Vassilaki M; Aakre JA; Mielke MM; Kremers WK; Machulda MM; Geda YE; Knopman DS; Petersen RC; Roberts RO
JAMA Neurol; 2016 Apr; 73(4):439-46. PubMed ID: 26831542
[TBL] [Abstract][Full Text] [Related]
6. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and amnestic mild cognitive impairment: Singapore Longitudinal Ageing Study-2 findings.
Feng L; Chong MS; Lim WS; Lee TS; Collinson SL; Yap P; Ng TP
J Alzheimers Dis; 2013; 34(3):649-57. PubMed ID: 23246920
[TBL] [Abstract][Full Text] [Related]
8. Identification of odors, faces, cities and naming of objects in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer´s disease: a longitudinal study.
Tahmasebi R; Zehetmayer S; Pusswald G; Kovacs G; Stögmann E; Lehrner J
Int Psychogeriatr; 2019 Apr; 31(4):537-549. PubMed ID: 30236169
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic--comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study.
Pusswald G; Moser D; Gleiss A; Janzek-Hawlat S; Auff E; Dal-Bianco P; Lehrner J
Alzheimers Dement; 2013 Jul; 9(4):366-76. PubMed ID: 23164551
[TBL] [Abstract][Full Text] [Related]
10. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
[TBL] [Abstract][Full Text] [Related]
11. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
12. Association of diabetes with amnestic and nonamnestic mild cognitive impairment.
Roberts RO; Knopman DS; Geda YE; Cha RH; Pankratz VS; Baertlein L; Boeve BF; Tangalos EG; Ivnik RJ; Mielke MM; Petersen RC
Alzheimers Dement; 2014 Jan; 10(1):18-26. PubMed ID: 23562428
[TBL] [Abstract][Full Text] [Related]
13. Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.
Krell-Roesch J; Vemuri P; Pink A; Roberts RO; Stokin GB; Mielke MM; Christianson TJ; Knopman DS; Petersen RC; Kremers WK; Geda YE
JAMA Neurol; 2017 Mar; 74(3):332-338. PubMed ID: 28135351
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
Ng TP; Feng L; Nyunt MS; Feng L; Gao Q; Lim ML; Collinson SL; Chong MS; Lim WS; Lee TS; Yap P; Yap KB
JAMA Neurol; 2016 Apr; 73(4):456-63. PubMed ID: 26926205
[TBL] [Abstract][Full Text] [Related]
15. Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.
Park SJ; Lee JE; Lee KS; Kim JS
Neurol Sci; 2018 Mar; 39(3):557-564. PubMed ID: 29383614
[TBL] [Abstract][Full Text] [Related]
16. Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.
Xu WL; Caracciolo B; Wang HX; Santoni G; Winblad B; Fratiglioni L
J Alzheimers Dis; 2013; 33(2):507-15. PubMed ID: 23247007
[TBL] [Abstract][Full Text] [Related]
17. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
[TBL] [Abstract][Full Text] [Related]
18. Conversion pattern and predictive factor of mild cognitive impairment in elderly Koreans.
Shim SM; Song J; Kim JH; Jeon JP
Arch Gerontol Geriatr; 2016; 64():146-50. PubMed ID: 26896864
[TBL] [Abstract][Full Text] [Related]
19. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.
Devanand DP; Lee S; Manly J; Andrews H; Schupf N; Doty RL; Stern Y; Zahodne LB; Louis ED; Mayeux R
Neurology; 2015 Jan; 84(2):182-9. PubMed ID: 25471394
[TBL] [Abstract][Full Text] [Related]
20. Mortality in mild cognitive impairment varies by subtype, sex, and lifestyle factors: the Mayo Clinic Study of Aging.
Vassilaki M; Cha RH; Aakre JA; Therneau TM; Geda YE; Mielke MM; Knopman DS; Petersen RC; Roberts RO
J Alzheimers Dis; 2015; 45(4):1237-45. PubMed ID: 25697699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
